Affinity Asset Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$2.18M | – | 89 |
|
|
2023
Q1 | $2.18M | Sell |
20,000
-25,000
| -56% | -$2.73M | 0.72% | 35 |
|
|
2022
Q4 | $5.12M | Buy |
+45,000
| New | +$5.12M | 2.01% | 15 |
|
|
2022
Q3 | – | Sell |
-75,000
| Closed | -$5.98M | – | 73 |
|
|
2022
Q2 | $5.98M | Buy |
75,000
+45,000
| +150% | +$3.59M | 2.52% | 10 |
|
|
2022
Q1 | $3.16M | Buy |
+30,000
| New | +$3.16M | 0.5% | 25 |
|
|
2021
Q4 | – | Sell |
-15,000
| Closed | -$1.64M | – | 85 |
|
|
2021
Q3 | $1.64M | Sell |
15,000
-10,000
| -40% | -$1.1M | 0.41% | 41 |
|
|
2021
Q2 | $2.34M | Sell |
25,000
-10,000
| -29% | -$936K | 0.84% | 23 |
|
|
2021
Q1 | $3.22M | Sell |
35,000
-10,000
| -22% | -$920K | 1.09% | 19 |
|
|
2020
Q4 | $3.29M | Buy |
+45,000
| New | +$3.29M | 1.74% | 13 |
|